Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

IDEAYA Biosciences, Inc.

CIK 1676725Updated Nov 5, 2026

IDYA price & chart

Provider market data

Loading TradingView…

NASDAQ:IDYA on TradingView ↗

TradingView · Data may be delayed

About the company

IDEAYA is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies to address unmet medical needs in cancer. The company integrates small-molecule drug discovery, structural biology and bioinformatics with extensive capabilities in identifying and validating translational biomarkers to develop potentially first-in-class targeted therapies for selected patient populations. IDEAYA has built a robust pipeline of targeted therapies focused on synthetic lethality and antibody-drug conjugates, or ADCs, including bispecifics, with the goal of improving clinical outcomes for patients with cancer.

8-K · 2026-11-03 · 0001193125-26-444225

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Financials

FY 2025 · USD
Revenue218,710,000USD · FY 2025
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

Net income-113,698,000USD · FY 2025
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

Operating income-159,313,000USD · FY 2025
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

Diluted EPS-1.28USD per share · FY 2025
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD1,185,136,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

1,239,873,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

1,309,699,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

1,041,270,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

973,663,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

1,030,348,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

1,100,641,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

961,527,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

1,109,324,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

1,124,091,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

649,316,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

387,969,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Property, Plant and Equipment, NetUSD8,172,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

8,235,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

8,280,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

8,819,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

7,122,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

8,634,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

8,871,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

6,909,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

8,217,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

8,966,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

6,164,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

6,509,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD298,927,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

400,283,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2024-09-30

272,589,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

114,645,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2025-06-30

183,049,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2024-06-30

157,522,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

129,996,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2025-03-31

108,345,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2024-03-31

112,825,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

84,378,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

157,018,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

68,632,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Assets, CurrentUSD802,655,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

932,214,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

864,025,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

685,602,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

713,179,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

696,107,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

707,872,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

709,353,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

666,727,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

689,713,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

532,632,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

370,454,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD15,761,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

12,165,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

19,653,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

15,864,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

11,520,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

18,346,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

15,364,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

10,566,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

21,366,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

13,391,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

7,500,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

5,414,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD23,544,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

18,385,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

22,179,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

23,913,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

1,305,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

22,613,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

24,428,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

1,780,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

23,068,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

18,775,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

2,246,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

2,484,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Other Assets, NoncurrentUSD————75,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

——92,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

——25,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

99,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD93,102,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

59,455,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

110,794,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

81,617,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

42,005,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

93,081,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

76,506,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

26,216,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

86,390,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

64,944,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

28,226,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

38,514,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD9,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

9,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

10,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

9,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

8,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

9,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

9,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

7,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

9,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

9,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

7,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

5,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-653,266,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

-492,529,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

-947,530,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

-772,510,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

-440,708,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

-835,078,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

-695,019,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

-387,936,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

-736,539,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

-622,841,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

-348,364,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

-235,403,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD2,052,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

3,836,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

-1,670,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

1,521,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

-1,416,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

-494,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

1,585,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

-923,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

2,267,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

812,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

562,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

-2,871,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD1,092,034,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

1,180,418,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2024-09-30

1,198,905,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

959,653,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2025-06-30

931,658,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2024-06-30

937,267,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

1,024,135,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2025-03-31

935,311,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2024-03-31

1,022,934,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

1,059,147,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

621,090,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

349,455,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Additional Paid in Capital, Common StockUSD1,743,239,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

1,669,102,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

2,148,095,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

1,730,633,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

1,373,774,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

1,772,830,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

1,717,560,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

1,324,163,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

1,757,197,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

1,681,167,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

968,885,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

587,724,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Liabilities and EquityUSD1,185,136,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

1,239,873,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

1,309,699,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

1,041,270,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

973,663,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

1,030,348,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

1,100,641,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

961,527,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

1,109,324,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

1,124,091,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

649,316,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

387,969,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD64,509,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

40,659,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

82,677,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

55,338,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

40,742,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

64,831,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

50,846,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

24,960,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

58,815,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

46,071,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

27,101,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

31,718,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Operating Lease, Liability, CurrentUSD328,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

0
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

1,190,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

318,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

606,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

350,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

308,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

1,151,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

339,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

298,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

1,747,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

1,871,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Accounts Payable, CurrentUSD18,433,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

12,567,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

30,508,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

17,270,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

15,886,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

20,736,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

17,631,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

6,290,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

17,584,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

15,421,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

6,598,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

4,280,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD26,917,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

18,796,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

28,117,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

26,279,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

1,263,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

28,250,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

25,660,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

1,256,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

27,575,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

18,873,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

1,125,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

1,611,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD45,258,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

28,092,000
Source

10-Q · 2024-11-04 · 0000950170-24-120675

As of 2024-09-30

50,979,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

37,750,000
Source

10-Q · 2025-08-05 · 0000950170-25-102967

As of 2025-06-30

24,250,000
Source

10-Q · 2024-08-06 · 0000950170-24-091823

As of 2024-06-30

43,745,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

32,907,000
Source

10-Q · 2025-05-06 · 0000950170-25-064438

As of 2025-03-31

17,519,000
Source

10-Q · 2024-05-07 · 0000950170-24-054466

As of 2024-03-31

40,892,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

30,352,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

18,756,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

16,999,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-98,539,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

-72,178,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

-113,698,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-274,477,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-112,961,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-58,655,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————688,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

600,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

2,700,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

2,387,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

2,476,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

2,101,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————14,536,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

10,237,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

46,115,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

34,746,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

18,489,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

11,629,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD————————0
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-15,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-193,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-892,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Increase (Decrease) in Accounts PayableUSD——————3,050,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

2,728,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

2,697,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

8,280,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

2,635,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

1,864,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-75,170,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

-60,342,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

-71,098,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-247,584,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-115,224,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-87,175,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————118,952,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

79,817,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

69,976,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-502,559,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-158,456,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-33,404,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————967,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

1,330,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

2,368,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

3,857,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

2,368,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

3,443,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————1,181,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

26,143,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

29,779,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

677,551,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

362,717,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

97,165,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————44,963,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

45,618,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

28,657,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-72,592,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

89,037,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-23,414,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——299,732,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2025-09-30

401,194,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

As of 2024-09-30

273,870,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2026-06-30

115,450,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

As of 2025-06-30

158,803,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2026-03-31

130,801,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

As of 2025-03-31

113,840,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

As of 2025-12-31

85,183,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

As of 2024-12-31

157,775,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

As of 2023-12-31

68,738,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD————————0
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

25,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

69,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

60,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Income Taxes Paid, NetUSD——————————0
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——12,217,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

9,215,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

16,658,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

11,868,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

14,536,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

10,237,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

46,115,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

34,746,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

18,489,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

11,629,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD———————————0
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——16,389,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

9,741,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

22,459,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

14,580,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

19,378,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

13,503,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

63,319,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

39,302,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

28,306,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

23,897,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——————0
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——119,244,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

-51,821,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

-112,452,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

-77,491,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

-98,539,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

-72,178,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

-113,698,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-274,477,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-112,961,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-58,655,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——10,792,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

15,072,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

9,839,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

11,315,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

10,005,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

12,211,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

45,615,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

52,498,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

21,468,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

3,847,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Operating ExpensesUSD——99,382,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

66,893,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

131,148,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

88,806,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

115,104,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

84,389,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

378,023,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

333,975,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

157,814,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

113,433,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD———————————1,700,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD————————0
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

274,350,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

281,165,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

86,105,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD——————162,529,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

186,354,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

680,233,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

692,607,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

439,892,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

—
Proceeds from Stock Options ExercisedUSD——————1,190,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

1,134,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

3,431,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

12,483,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

9,559,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

1,448,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——207,834,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

0
Source

10-Q · 2024-11-04 · 0000950170-24-120675

2024-07-01 to 2024-09-30

8,857,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

—6,560,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

—218,710,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

7,000,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

23,385,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

50,931,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——108,452,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

-66,893,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

-122,291,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

-88,806,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

-108,544,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

-84,389,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

-159,313,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-326,975,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-134,429,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-62,502,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——————0
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——119,244,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

-51,821,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

-112,452,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

-77,491,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

-98,539,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

-72,178,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

-113,698,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-274,477,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-112,961,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-58,655,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——1.35
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

-0.6
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

-1.22
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

-0.88
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

-1.11
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

-0.82
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

-1.28
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-3.36
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-1.96
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-1.42
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——1.33
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

-0.6
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

-1.22
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

-0.88
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

-1.11
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

-0.82
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

-1.28
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

-3.36
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

-1.96
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

-1.42
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——88,526,781
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

86,188,510
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

92,061,452
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

88,472,197
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

88,699,754
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

88,356,335
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

88,485,238
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

81,678,069
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

57,519,929
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

41,444,696
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——89,690,878
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

86,188,510
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

92,061,452
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

88,472,197
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

88,699,754
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

88,356,335
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

88,485,238
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

81,678,069
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

57,519,929
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

41,444,696
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD——700,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

600,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

700,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

700,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

700,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

600,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

2,700,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

2,400,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

2,500,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

2,100,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——16,389,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

9,741,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

22,459,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

14,580,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

19,378,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

13,503,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

63,319,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

39,302,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

28,306,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

23,897,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——10,792,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

15,072,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

9,839,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

11,315,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

10,005,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

12,211,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

45,615,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

52,498,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

21,468,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

3,847,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Operating ExpensesUSD——99,382,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

66,893,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

131,148,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

88,806,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

115,104,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

84,389,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

378,023,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

333,975,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

157,814,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

113,433,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD———————————1,700,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——82,993,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2025-07-01 to 2025-09-30

57,152,000
Source

10-Q · 2025-11-04 · 0001193125-25-264632

2024-07-01 to 2024-09-30

108,689,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2026-04-01 to 2026-06-30

74,226,000
Source

10-Q · 2026-08-04 · 0001193125-26-332774

2025-04-01 to 2025-06-30

95,726,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2026-01-01 to 2026-03-31

70,886,000
Source

10-Q · 2026-05-05 · 0001193125-26-206357

2025-01-01 to 2025-03-31

314,704,000
Source

10-K · 2026-02-17 · 0001193125-26-054533

2025-01-01 to 2025-12-31

294,673,000
Source

10-K · 2025-02-18 · 0000950170-25-022183

2024-01-01 to 2024-12-31

129,508,000
Source

10-K · 2024-02-20 · 0000950170-24-017093

2023-01-01 to 2023-12-31

89,536,000
Source

10-K · 2023-03-07 · 0000950170-23-006456

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-295560

S-3ASR · 2026-05-05 · 0001193125-26-206523

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

idya-ex99_1.htm · 8-K · 2026-11-03

Exhibit 99.1 IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update • Data presented at ESMO 2026 collectively supports the potential of darovasertib to become a foundational new therapy across the treatment journey of uveal melanoma in both primary and metastatic disease, irrespective of HLA-A*02:01 allele status or line of therapy • Completed NDA submission in Q3’26 to support the potential U.S. approval of darovasertib plus crizotinib in meta…

8-K · 2026-11-03 · 0001193125-26-444225

Read attachment ↗
idya-ex99_1.htm · 8-K · 2026-08-04

EX-99.1 2 idya-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update • Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing is underway under the real-time oncology review program (RTOR) with completion expected in H2 2026 • Updated data from Phase 2 OptimUM-01 trial (HLA*A2-positive mUM patient subset) a…

8-K · 2026-08-04 · 0001193125-26-331381

Read attachment ↗
d110954dex41.htm · 8-K · 2026-06-10

EX-4.1 3 d110954dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 IDEAYA BIOSCIENCES, INC. FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK Number of Shares: [    ] (subject to adjustment) Warrant No. Original Issue Date: [ ], 2026 IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ] or its registered assigns (the “Holder”), is entitled, subject to the…

8-K · 2026-06-10 · 0001193125-26-265833

Read attachment ↗
d138848dex991.htm · 8-K · 2026-06-01

EX-99.1 2 d138848dex991.htm EX-99.1 EX-99.1 Darovasertib Plus Crizotinib vs Investigator’s Choice as First-Line Treatment for Patients with HLA-A2 Negative Metastatic Uveal Melanoma: Primary Results from the OptimUM-02 Trial Marlana Orloff,1 Egle Ramelyte,2 Marcus O. Butler,3 Piotr Rutkowski,4 Lorenza Di Guardo,5 Matteo S. Carlino,6 Bartosz Chmielowski,7 Lucy Kennedy,8 Kamaneh Montazeri,9 Joseph Sacco,10 Ernesto Rossi,11 Victoria Atkinson,12 Rizwan Haq,13 Meredith McKean,14 George Cole,15 H…

8-K · 2026-06-01 · 0001193125-26-251399

Read attachment ↗
d83661dex43.htm · S-3ASR · 2026-05-05

Exhibit 4.3 IDEAYA BIOSCIENCES, INC. INDENTURE Dated as of ___________, 20___ [    ] Trustee TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1. Definitions 1 Section 1.2. …

S-3ASR · 2026-05-05 · 0001193125-26-206523

Read attachment ↗
idya-ex99_1.htm · 8-K · 2026-05-05

EX-99.1 2 idya-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update • Phase 2/3 registrational trial (OptimUM-02) of darovasertib combination met its primary endpoint; complete data will be provided in a late-breaking oral presentation at ASCO • IDEAYA to initiate RTOR submission process with first pre-submission in May; targeting completion of the NDA filing in H2 2026 • Clinical updates from Phase 2 OptimU…

8-K · 2026-05-05 · 0001193125-26-204944

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.